Skip to main content

Influence of biospecimen variables on proteomic biomarkers in breast cancer.

Meric-Bernstam F, Akcakanat A, Chen H, Sahin A, Tarco E, Carkaci S, Adrada BE, Singh G, Do KA, Garces ZM, Mittendorf E, Babiera G, Bedrosian I, Hwang R, Krishnamurthy S, Symmans WF, Gonzalez-Angulo AM, Mills GB

Publication: Clin Cancer Res (2014) • Vol 20 • Page 3870-83PMID: 24895461View on PubMed

Purpose

This paper compared protein profiles of case-matched fine needle aspiration (FNA), core needle biopsy (CNB), as well as surgical resection specimens sampled from the center and periphery of the tumor. Effects of surgery type; cold ischemia time; patient age; adjuvant chemotherapy; and tumor size, cellularity and grade on correlated protein expression between specimen types was also explored.

Conclusion

Functional protein profiles of FNA specimens clustered separately from those of CNB and resection specimens, while other specimen types generally clustered together by patient rather than by specimen type. Levels of phosphorylated proteins were less correlated among specimen types than levels of non-phosphorylated proteins, but the effect was only significant between FNA and resection specimens. When functional protein profiles were compared, protein levels were comparable for 97% of proteins between the tumor periphery and center of surgical resection specimens (149/154), 63% of proteins between resection and CNB specimens (97/154), and 32% of proteins between resection and FNA specimens (49/154). Importantly, there was 74.4% and 78.4% agreement in phosphatidylinositol 3-kinase (PI3K) activation status between specimens from the tumor center and periphery of resection specimens, and between CNB and resection specimens, respectively. However, CNB specimens showed more signs of PI3K activation.

Correlations between specimens were stronger when they were subjected to less than 36.7 min cold ischemia and that were obtained during breast conservation rather than mastectomy from patients who did not receive adjuvant chemotherapy. Further, correlations between specimens from the tumor core and periphery of surgical resections were strongest among tumors smaller than 3.6 cm; however, correlations between surgical resection and FNA specimens were strongest among specimens from tumors greater than 3.6 cm.  Compared to younger patients, patients older than 51 years had higher levels of estrogen receptor (ER) in both CNB and resection specimens (from the center or periphery of the tumor), and lower levels of TP53-induced glycolysis and apoptosis regulator (TIGAR) and c-Kit in CNB.

Studies (2)

Purpose

The purpose of this study was to compare protein profiles of case-matched specimens obtained by FNA, CNB, and surgical resection from the center and periphery of the tumor. Profiles were generated by reverse phase protein arrays (RPPA) and immunohistochemistry (IHC). Intraoperative ultrasound-guided percutaneous FNAs (4–8 passes) and CNBs (3–4 core biopsies) were obtained from 53 patients with lesions greater than 2 cm prior to surgical resection. FNA specimens, the largest CNB, and portions of the surgical resection from each patient were frozen for RPPA, and the remaining CNB and surgical resection specimens were formalin-fixed and paraffin-embedded for H&E and IHC staining. RPPA investigated levels of 154 proteins (enriched for PI3K/Akt/mTOR pathways) in specimens with greater than 20% tumor content on the corresponding H&E specimen (44 CNBs, 46 resection specimens from the tumor center, and 43 resection specimens from the tumor periphery). RPPA was normalized for FNA and CNB specimens independently. For each specimen an overall PI3K pathway score was calculated by adding normalized values and the specimen was classified as active if the sum was in the top quarter for their sample type.

Summary of Findings

There were no differences in tumor content between resection specimens from the tumor center and periphery; however, CNB specimens had significantly lower tumor content than resection specimens from the periphery (52.7% versus 60.7%, P=0.048). Functional protein profiles of FNA specimens clustered separately but CNB and resection specimens clustered together by patient rather than by procurement methods. Levels of phosphorylated proteins were less correlated among procurement methods than non-phosphorylated proteins, but significant differences were limited to FNA and resection specimens (P=0.04). Correlations between IHC and RPPA staining were noted for pAkt S473 (r=0.71), PTEN (r=0.41), and pS6 S235/236 (r=0.33) among resection specimens from the tumor center and for pAkt S473 in surgical resection specimens from the tumor periphery (r=0.65), and CNB specimens (r=0.52). Expression levels in resection specimens from the tumor periphery and center were significantly correlated for 149 of the 154 proteins evaluated, but levels of caveolin, eEF2, pJNK T183/185, p-mTOR S2448, PRAS40 T246, and pSrc Y527 were not. Importantly, the strength of correlations for RPPA-determined protein levels varied in a protein-specific manner between resection specimens from the center and periphery: ER (r=0.90), PR (r=0.90), HER2 (r=0.79), pAKT S473 (r=0.70), pAkt T308 (r=0.61), PTEN (r=0.72), INPP4B (r=0.77), p4E-BP1 T37/46 (r=0.62), p4E-BP1 S65 (r=0.53), pS6 S235/236 (r=0.42), and pS6 240/244 (r=0.44). Using a false discovery rate (FDR) of 0.05, there was no difference in expression between the periphery and the core for 132 of the 154 markers (86%) and there was 74.4% agreement in PI3K activation status. Similarly, IHC showed modest to strong correlations in p4E-BP1 T70, pAkt S473 pPRAS40 T246, pS6 S240/244, pS6 S235/236, and PTEN expression between specimens from the tumor center and periphery (r=0.81, r=0.588, r=0.82, r=0.55, r=0.48, r=0.82, r=0.55, r=0.48, and r=0.85, respectively).

Using a FDR of 0.05, resection specimens and CNB had comparable levels of 97 of the 154 markers (67%). Importantly, weak to strong correlations for RPPA levels between resection specimens and CNB were observed for levels of ER (r=0.80), PR (r=0.87), HER2 (r=0.66), pAKT S473 (r=0.60), pAkt T308 (r=0.60), PTEN (r=0.72), INPP4B (r=0.77), p4E-BP1 T37/46 (r=0.35), p4E-BP1 S65 (r-0.32), and pS6 240/244 (r=0.36). Correlations of similar strength were observed for IHC staining between CNB and the resection specimen from the core for pAkt S473, PTEN, p4E-BP1 T70 and pS6 S235/236 (r=0.87, r=0.72, r=0.81, and r-0.38, respectively), and between the CNB and peripheral resection specimen for pAkt S473, PTEN, p4E-BP1 S65, pS6 S240/244, and pS6 S235/236 (r=0.71, r=0.68, r=0.63, r=0.47, and r=0.49, respectively). There was 78.4% agreement in PI3K activation status between CNB and resection specimens from the tumor center. Compared to resection specimens from the core, PI3K activation was higher in CNB as determined by RPPA levels of pAkt S473 (P=0.02), p4E-BP1 S65 (P=0.03), p4E-BP1 S37/46 (P<0.001), pS6 S235/236 (P=0.01) pS6 S240/244 (P<0.001), PTEN (P<0.001), and pMAPK T202/204 (P=0.004), but only p4E-BP1 T37/46 and pS6 240/244 levels were significantly higher in CNB than the resection specimen (P=0.005 and P<0.001, respectively).

In contrast, of the 154 proteins evaluated, only 49 proteins were significantly correlated between FNA and resection specimens and 68 proteins between FNA and CNB specimens (p<0.05). Modest correlations between FNA and surgical resection or CNB specimens were noted for ER (r=0.606 and r=0.650, respectively) and PR (r=.70 and r=0.64, respectively) and a weak-modest correlation for HER-2 levels (r=0.37 and r=0.57, respectively). IHC staining of pAkt S473, PTEN, and pS6 S235/236 in the resection specimen was weakly correlated with RPPA levels in the FNA specimen (r=0.30, r=0.37 and r=0.35, respectively).

  • Biospecimens

    TissueBreast
  • Preservation Types

    FormalinFrozen
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinReverse phase protein microarray
    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionMethod of tissue acquisition
    Core needle biopsy
    Fine needle aspiration
    Surgical resection
    Immunohistochemistry SpecificTargeted peptide/protein
    PTEN
    ki-67
    p4EBP1 T70
    pAkt S473
    pPRAS40 T246
    pS6 S235/236
    pS6 S240/244
    Immunohistochemistry SpecificTechnology platform
    RPPA